Rain Therapeutics Inc. (RAIN) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET
Company Participants
Bob Yedid – LifeSci Advisors
Avanish Vellanki – Chief Executive Officer
Nelson Cabatuan – Senior Vice President of Finance
Bob Deobele – President and Chief Scientific Officer
Richard Bryce – Chief Medical Officer
Conference Call Participants
Yige Guo – Guggenheim
Sam Kurtz – Piper Sandler
Jeff Jones – Oppenheimer
Soumit Roy – Jones Research
Tony Butler – ROTH Capital
Operator
Good day, and welcome to the Rain Therapeutics Second Quarter 2022 Earnings Conference Call. Today’s conference is being recorded.
At this time, I’d like to turn the conference over to Bob Yedid. Please go ahead.
Bob Yedid
Thank you, operator, and good afternoon, everyone. With me today on the call are Avanish Vellanki, Chief Executive Officer of Rain Therapeutics; Nelson Cabatuan, SVP of Finance. During today’s call, Avanish will provide an overall business update, including Rain’s clinical programs and research efforts, and Nelson will review the financials.
Before we begin, I’d like to remind you that statements made during this conference call that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Rain’s current expectations and involve assumptions that may never materialize or may prove to be incorrect.
Actual results may differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties as described in Rain’s annual report on Form 10-K for the year ended December 31, 2021, and subsequent filings with the Securities and Exchange Commission.
All forward-looking statements made during this conference call are based on management’s assumptions and estimates as of today, August 4, 2022. Rain undertakes no obligation to update such statements to reflect events that occur or circumstances that
- Read more current RAIN analysis and news
- View all earnings call transcripts